SCHEMBL31279643

SCHEMBL31279643

O=C1CCN(N2C(=O)c3ccc(CN4CC=C(c5cncc(Cl)c5)CC4)cc3C2=O)C(=O)N1

nearest known ligand 0.47

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 6/20 0.47
IKZF1 Q13422 2/20 0.40
DRD4 P21917 7/20 0.38
DRD2 P14416 6/20 0.38
DRD3 P35462 5/20 0.38
EGLN1 Q9GZT9 1/20 0.38
HTR1A P08908 1/20 0.37
OPRM1 P35372 1/20 0.36
OPRK1 P41145 1/20 0.36
IKZF2 Q9UKS7 1/20 0.36
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31279785 0.86 IKZF1 (0.46) PARP1IKZF1DRD4DRD2DRD3
SCHEMBL31279212 0.86 PARP1 (0.39) PARP1IKZF1DRD4DRD2DRD3
SCHEMBL31338397 0.82 IKZF1 (0.55) PARP1IKZF1OPRM1IKZF2
SCHEMBL31279744 0.81 PARP1 (0.42) PARP1IKZF1DRD4DRD2HTR1A
SCHEMBL31279432 0.81 PARP1 (0.41) PARP1IKZF1DRD4DRD2DRD3
SCHEMBL31279413 0.81 PARP1 (0.39) PARP1IKZF1DRD4DRD2DRD3
SCHEMBL31279476 0.81 PARP1 (0.40) PARP1IKZF1DRD4DRD2DRD3
SCHEMBL31279058 0.80 PARP1 (0.39) PARP1IKZF1DRD4DRD2DRD3
SCHEMBL31279714 0.80 PARP1 (0.40) PARP1IKZF1DRD4DRD2HTR1A
SCHEMBL31279600 0.79 PARP1 (0.39) PARP1IKZF1DRD4DRD2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4722207-A1 OXOISOINDOLINYL-SUBSTITUTED TETRAHYDROPYRIMIDINEDIONE DERIVATIVE AND USE THEREOF Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) 2026-04-08 EP claimed
CN-119451952-A Oxo-isoindolinyl substituted tetrahydropyrimidinedione derivative and application thereof 标新生物医药科技(上海)有限公司 2025-02-14 CN claimed
WO-2024245444-A1 OXOISOINDOLINYL-SUBSTITUTED TETRAHYDROPYRIMIDINEDIONE DERIVATIVE AND USE THEREOF 标新生物医药科技(上海)有限公司 2024-12-05 WO claimed
EP-4722207-A1 OXOISOINDOLINYL-SUBSTITUTED TETRAHYDROPYRIMIDINEDIONE DERIVATIVE AND USE THEREOF Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) 2026-04-08 EP disclosed
CN-119451952-A Oxo-isoindolinyl substituted tetrahydropyrimidinedione derivative and application thereof 标新生物医药科技(上海)有限公司 2025-02-14 CN disclosed
WO-2024245444-A1 OXOISOINDOLINYL-SUBSTITUTED TETRAHYDROPYRIMIDINEDIONE DERIVATIVE AND USE THEREOF 标新生物医药科技(上海)有限公司 2024-12-05 WO disclosed